Zobrazeno 1 - 10
of 5 769
pro vyhledávání: '"Gendolla A"'
Autor:
Kreibig, Sylvia D.
Publikováno v:
In International Journal of Psychophysiology September 2017 119:93-107
Autor:
Riha, Karl, author
Publikováno v:
Anderes als Kunst: Ästhetik und Techniken der Kommunikation. :155-162
Autor:
Charly Gaul, Astrid Gendolla, Dagny Holle, Hartmut Göbel, Mirja Koch, Caroline Baufeld, Cordula Weiss
Publikováno v:
Pain and Therapy, Vol 13, Iss 6, Pp 1659-1678 (2024)
Abstract Introduction To provide real-world insights into migraine patient population in Germany treated with erenumab, focusing on the prescription patterns and reasons for the initial dosage choice. Methods SPECTRE was an observational, non-interve
Externí odkaz:
https://doaj.org/article/3701ab0ad96340c9a470db1ffe5a074b
Autor:
Framorando, David1 (AUTHOR), Gendolla, Guido H. E.1 (AUTHOR) guido.gendolla@unige.ch
Publikováno v:
Swiss Psychology Open. 2023, Vol. 3 Issue 1, p1-10. 9p.
Autor:
Gaul, Charly1 (AUTHOR) c.gaul@kopfschmerz-frankfurt.de, Gendolla, Astrid2 (AUTHOR), Holle, Dagny3 (AUTHOR), Göbel, Hartmut4 (AUTHOR), Koch, Mirja5 (AUTHOR), Baufeld, Caroline6 (AUTHOR), Weiss, Cordula6 (AUTHOR)
Publikováno v:
Pain & Therapy. Dec2024, Vol. 13 Issue 6, p1659-1678. 20p.
Autor:
Bouzidi, Yann S.1,2 (AUTHOR) yann.bouzidi@unige.ch, Gendolla, Guido H. E.1,2 (AUTHOR) guido.gendolla@unige.ch
Publikováno v:
Psychophysiology. May2023, Vol. 60 Issue 5, p1-11. 11p. 4 Charts, 1 Graph.
Autor:
Bouzidi, Yann S.1 (AUTHOR) guido.gendolla@unige.ch, Gendolla, Guido H. E.1 (AUTHOR)
Publikováno v:
Psychophysiology. Feb2023, Vol. 60 Issue 2, p1-16. 16p. 1 Diagram, 4 Charts, 2 Graphs.
Autor:
Gendolla, Guido H. E.1,2 (AUTHOR) guido.gendolla@unige.ch
Publikováno v:
Motivation & Emotion. Dec2022, Vol. 46 Issue 6, p889-893. 5p.
Autor:
Stöber, Rudolf
Publikováno v:
Jahrbuch für Kommunikationsgeschichte, 2015 Jan 01. 17, 256-256.
Externí odkaz:
http://www.jstor.org/stable/24753401
Autor:
Armin Scheffler, Pauline Wenzel, Merle Bendig, Astrid Gendolla, Jale Basten, Christoph Kleinschnitz, Michael Nsaka, Diana Lindner, Steffen Naegel, Philipp Burow, Robert Fleischmann, Dagny Holle
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Eptinezumab is a monoclonal antibody that targets calcitonin gene-related peptide (CGRP mAb) and is used for migraine prophylaxis. Efficacy data are mainly from clinical trials, real-world data are hardly available yet. Reimbursem
Externí odkaz:
https://doaj.org/article/5f1fd9fe00a7444eb098894b6f3673ca